🚀 Special Launch Offer🚀 20% off your first XtenCHO™ Race Starter Kit, until May 31. 2025. Code XTEN20

Order now

XtenCHO ™ Expression medium

Reference: PX-XTE-002
Brand

ProteoGenix

Product type

XtenCHO

Size

XtenCHO ™ Expression medium

Product nameXtenCHO ™ Expression medium
Expression systemMammalian
Delivery conditionBlue ice (+4°C)
Delivery lead time in business daysEurope: 2-4 business days
USA & Canada: 2-4 business days
Rest of the world: 5-10 business days
Storage condition4°C
BrandProteoGenix
Host speciesMammalian cells
ReferencePX-XTE-002
NoteFor research use only.
Kit Content1L bottle
Limited Use Label LicensesLimited Use Label License for internal Research and Development Use of Mammalian Cell Lines

Description of XtenCHO ™ Expression medium

XtenCHO™ Expression Medium: Optimized for High-Yield CHO Cell Protein Production

The XtenCHO™ Expression Medium is specifically formulated for small to medium-scale recombinant protein production in Chinese Hamster Ovary (CHO) cells. This serum-free, animal-component-free, and chemically defined medium ensures high reproducibility and batch-to-batch consistency, providing researchers with a reliable and optimized culture environment. Its serum-free composition significantly enhances transfection efficiency, while its formulation supports balanced cell growth and viability in suspension cultures.

When used in combination with XtenCHO™ Race Cells and the XtenCHO™ Race Transfection Kit, this system has achieved an exceptional antibody production yield of 904 mg/L, making it a market leader in transient gene expression.
How to Use XtenCHO™ Expression Medium

The XtenCHO™ Expression Medium is designed for high-efficiency transient transfection, supporting volumes from a few milliliters to 10 liters. It serves both for transfection and cell sub-culturing, simplifying experimental workflows and reducing variability in conditions.

The XtenCHO™ Starter Kit includes comprehensive protocols for seamless integration into various lab setups, ensuring ease of use and adaptability.

Supplementation Requirements

For optimal transfection results, XtenCHO™ Expression Medium requires additional supplementation with:

L-Glutamine (8mM): A crucial nutrient for cell metabolism and growth. However, due to its rapid hydrolysis, regular supplementation is necessary to maintain its effective concentration and avoid toxic byproducts.
Anti-Clumping Agent (0.5%): Prevents cell aggregation in suspension cultures. However, it should not be added during transfection, as it can negatively impact protein yields.

Culture Conditions

For best results, use XtenCHO™ Expression Medium in:

-Sterile, vented, baffled Erlenmeyer shake flasks
-Incubator shaker set at 37°C, ≥80% relative humidity, and 5% CO₂

The XtenCHO™ Expression Medium is an essential component of the XtenCHO™ Race Starter Kit but is also available separately for worldwide delivery, ensuring flexibility for diverse research needs.

XtenCHO™ Race outperforms up to 6X (Cixutumumab and Peresolimab)

Crude production yields in mg/L obtained in 24-well plates cultures without feeding (Octet Analysis) Yields in flask (better aeration) will be 1.5 to 2.5 Higher for Human/humanized IgG1/IgG4 (depending on the antibody considered)

Publication

  • Luo K, Chen Y, Wang F. Shrimp Plasma MANF Works as an Invertebrate Anti-Inflammatory Factor via a Conserved Receptor Tyrosine Phosphatase. J Immunol. 2022 Mar 1;208(5):1214-1223. doi: 10.4049/jimmunol.2100595. Epub 2022 Feb 11. PMID: 35149533.
  • Bonduelle O, Chaudesaigues C, Tolazzi M, Suleiman E, de Bernard S, Alves K, Nourikyan J, Bohec M, Baudrin LG, Katinger D, Debré P, Scarlatti G, Vieillard V, Combadière B. Dichotomy in Neutralizing Antibody Induction to Peptide-Conjugated Vaccine in Squalene Emulsion Contrast With Aluminum Hydroxide Formulation. Front Immunol. 2022 Apr 7;13:848571. doi: 10.3389/fimmu.2022.848571. PMID: 35464449; PMCID: PMC9021396.
  • Sandberg, A., Berenjeno-Correa, E., Rodriguez, R.C. et al. Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts. Alz Res Therapy 14, 196 (2022). https://doi.org/10.1186/s13195-022-01141-1
  • Villatoro, A., Cuminetti, V., Bernal, A. et al. Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation. Nat Commun 14, 12 (2023). https://doi.org/10.1038/s41467-022-35700-9
  • Michel Cogne, Natsuko UEDA, Marine CAHEN et al. Single-hit genome editing in B cells to redirect their specificity toward tumor antigens, 06 May 2024, PREPRINT (Version 1) available at Research Square [https://doi.org/10.21203/rs.3.rs-4317490/v1]

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “XtenCHO ™ Expression medium”

Your email address will not be published. Required fields are marked *

Related products

XtenCHO ™ Starter kit
XtenCHO

XtenCHO ™ Starter kit

PX-XTE-001 1880$
XtenCHO ™ Expression medium
XtenCHO

XtenCHO ™ Expression medium

PX-XTE-002 351$
XtenCHO ™ Cells
XtenCHO

XtenCHO ™ Cells

PX-XTE-004 1523$
XtenCHO ™ Cell Bank Pack
XtenCHO

XtenCHO ™ Cell Bank Pack

PX-XTE-005 2615$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products